http://www.pharmareform.com/ 2010-09-04T18:58:15+00:00 daily 1.0 http://www.pharmareform.com/2010/09/04/professional-pharmaceutical-representatives%e2%80%a6-what%e2%80%99s-on-your-bookshelf/ 2010-09-04T18:58:15+00:00 monthly 0.6 http://www.pharmareform.com/2010/09/02/are-pharmaceutical-executives-hampering-the-ability-of-their-companies-to-change/ 2010-09-03T01:03:25+00:00 monthly 0.6 http://www.pharmareform.com/2010/08/31/what-does-your-ceo-thinks-about-pharmaceutical-sales-representatives/ 2010-09-02T18:58:58+00:00 monthly 0.6 http://www.pharmareform.com/about/ 2010-09-01T15:55:25+00:00 weekly 0.6 http://www.pharmareform.com/2010/08/24/pharmaplasia%e2%84%a2-kindle-edition-now-available-at-amazon-com/ 2010-08-24T15:23:41+00:00 monthly 0.6 http://www.pharmareform.com/pharmaplasia-tm/ 2010-08-24T01:48:26+00:00 weekly 0.6 http://www.pharmareform.com/2010/08/23/professional-pharmaceutical-representatives-will-be-in-high-demand/ 2010-08-23T16:39:12+00:00 monthly 0.6 http://www.pharmareform.com/2010/08/19/plenty-of-work-for-pharmaceutical-sales-representatives-if-only/ 2010-08-19T17:56:10+00:00 monthly 0.6 http://www.pharmareform.com/2010/08/17/can-pharmaceutical-sales-representatives-still-add-value/ 2010-08-17T16:08:46+00:00 monthly 0.6 http://www.pharmareform.com/2010/08/16/it%e2%80%99s-not-just-a-pharmaceutical-sales-representative-problem/ 2010-08-16T16:05:48+00:00 monthly 0.6 http://www.pharmareform.com/consulting-services/ 2010-08-11T17:21:43+00:00 weekly 0.6 http://www.pharmareform.com/invite-mike-to-speak/ 2010-08-11T17:06:21+00:00 weekly 0.6 http://www.pharmareform.com/2010/08/11/high-prescription-drug-prices-pay-for-more-than-the-high-cost-of-r-d/ 2010-08-11T14:46:54+00:00 monthly 0.6 http://www.pharmareform.com/2010/08/10/secret-low-cost-high-revenue-generating-strategies-for-pharmaceutical-companies/ 2010-08-10T11:58:32+00:00 monthly 0.6 http://www.pharmareform.com/2010/08/02/how-will-your-pharma-company-do-with-healthcare-reform/ 2010-08-02T18:21:14+00:00 monthly 0.6 http://www.pharmareform.com/2010/07/29/who-is-killing-the-pharmaceutical-sales-position/ 2010-07-29T14:02:52+00:00 monthly 0.6 http://www.pharmareform.com/2010/07/20/healthcare-reform-implications-for-the-pharmaceutical-industry-highlighted-in-new-book-pharmaplasia%e2%84%a2-published-by-pharmareform-com-author-mike-wokasch/ 2010-07-21T12:36:55+00:00 monthly 0.6 http://www.pharmareform.com/2010/07/19/pharmaceutical-industry-physicians-and-scientists-are-the-key-to-reestablishing-trust/ 2010-07-20T15:08:34+00:00 monthly 0.6 http://www.pharmareform.com/frontpage/ 2010-07-19T22:19:14+00:00 weekly 0.6 http://www.pharmareform.com/2010/07/14/perceptions-of-the-pharmaceutical-industry-can-make-normal-business-practices-seem-unethical-or-illegal/ 2010-07-14T16:21:23+00:00 monthly 0.6 http://www.pharmareform.com/2010/07/07/commercially-successful-off-label-promotion-should-be-an-embarrassment-to-the-medical-profession/ 2010-07-07T17:55:19+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/29/we-hate-your-financial-influence-but-we-like-your-money/ 2010-06-29T13:49:17+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/24/hidden-upside-for-pharmaceutical-pricing-in-healthcare-reform/ 2010-06-24T16:01:06+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/22/is-the-big-pharma-biotech-well-going-to-run-dry/ 2010-06-22T19:51:57+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/17/healthcare-reformed-pharmaceutical-companies-%e2%80%93-future-reality-or-too-idealistic/ 2010-06-17T15:09:57+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/14/are-big-pharma-companies-becoming-pharmaceutical-big-box-outlets-for-the-healthcare-market/ 2010-06-14T14:34:12+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/07/skillful-diligent-management-oversight-is-better-than-autonomy-for-the-pharmaceutical-industry/ 2010-06-07T14:49:24+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/03/healthcare-market-considerations-for-eliminating-pharmaceutical-sales-representatives/ 2010-06-04T00:55:39+00:00 monthly 0.6 http://www.pharmareform.com/2010/06/01/healthcare-market-perceptions-create-expectations-for-pharmaceutical-companies/ 2010-06-01T15:52:31+00:00 monthly 0.6 http://www.pharmareform.com/2010/05/28/healthcare-customer-frustrations-with-big-pharma/ 2010-05-28T13:18:54+00:00 monthly 0.6 http://www.pharmareform.com/2010/05/26/delivering-on-comparative-value-expectations-for-the-healthcare-market/ 2010-05-26T23:14:36+00:00 monthly 0.6 http://www.pharmareform.com/2010/05/25/healthcare-reform-comparative-effectiveness-will-really-mean-comparative-value/ 2010-05-25T19:10:08+00:00 monthly 0.6 http://www.pharmareform.com/2010/05/18/is-the-%e2%80%9cbig%e2%80%9d-in-big-pharma-a-value-creator-or-liability/ 2010-05-18T15:08:53+00:00 monthly 0.6 http://www.pharmareform.com/2010/05/11/biotech-a-source-for-big-pharma-innovative-new-products/ 2010-05-11T15:31:36+00:00 monthly 0.6 http://www.pharmareform.com/2010/05/06/healthcare-reform-and-a-world-without-big-pharma/ 2010-05-06T14:15:44+00:00 monthly 0.6 http://www.pharmareform.com/2010/04/30/are-investors-in-pharmaceutical-companies-being-duped-or-rewarded/ 2010-04-30T17:54:10+00:00 monthly 0.6 http://www.pharmareform.com/2010/04/18/moral-dilemma-and-the-ethics-of-pharmaceutical-marketing/ 2010-04-19T15:23:05+00:00 monthly 0.6 http://www.pharmareform.com/2010/04/11/pharmaceutical-sales-healthcare-reform-survival-guide/ 2010-04-11T16:10:17+00:00 monthly 0.6 http://www.pharmareform.com/2010/04/05/preparing-pharmaceutical-company-employees-for-the-impact-of-healthcare-reform/ 2010-04-05T14:50:04+00:00 monthly 0.6 http://www.pharmareform.com/2010/04/02/prescription-drug-evaluations-under-healthcare-reform/ 2010-04-02T18:34:57+00:00 monthly 0.6 http://www.pharmareform.com/2010/03/30/healthcare-reform-driven-marketing-challenges-to-stimulating-product-interest/ 2010-03-30T14:25:20+00:00 monthly 0.6 http://www.pharmareform.com/2010/03/29/healthcare-reform-impact-on-pharmaceutical-marketing/ 2010-03-29T14:51:05+00:00 monthly 0.6 http://www.pharmareform.com/2010/03/22/healthcare-reform-impact-on-prescription-drugs/ 2010-03-22T13:50:50+00:00 monthly 0.6 http://www.pharmareform.com/2010/03/12/my-10-favorite-sources-of-pharmaceutical-biotech-and-healthcare-reform-news/ 2010-03-12T19:17:38+00:00 monthly 0.6 http://www.pharmareform.com/2010/03/11/can-the-pharmaceutical-industry-be-trusted-to-use-of-social-media/ 2010-03-11T16:44:12+00:00 monthly 0.6 http://www.pharmareform.com/2010/02/28/pharmaceutical-pricing-practices-must-change-to-reestablish-market-trust/ 2010-02-28T19:28:03+00:00 monthly 0.6 http://www.pharmareform.com/2010/02/21/5-step-assessment-for-reestablishing-trust-in-pharmaceutical-marketing/ 2010-02-22T14:41:03+00:00 monthly 0.6 http://www.pharmareform.com/2010/02/12/reestablishing-pharmaceutical-industry-trust-starts-with-integrity-at-the-top/ 2010-02-12T15:42:22+00:00 monthly 0.6 http://www.pharmareform.com/2010/02/07/5-major-sources-of-market-distrust-of-the-pharmaceutical-industry/ 2010-02-10T00:49:41+00:00 monthly 0.6 http://www.pharmareform.com/2010/02/09/5-steps-to-restoring-trust-in-the-pharmaceutical-industry/ 2010-02-10T00:47:13+00:00 monthly 0.6 http://www.pharmareform.com/2010/02/01/marketing-and-sales-challenges-in-the-evolving-new-healthcare-market/ 2010-02-01T16:29:53+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/29/a-non-executive%e2%80%99s-plan-for-initiating-organizational-change/ 2010-01-29T21:15:48+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/27/the-challenge-for-non-executives-who-see-a-need-for-change-at-pharmaceutical-companies/ 2010-01-27T19:11:50+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/21/strong-science-makes-for-more-credible-marketing-and-sales/ 2010-01-22T00:45:17+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/20/pharmaceutical-industry%e2%80%99s-missed-r-d-opportunities/ 2010-01-20T17:44:03+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/19/pharmaceutical-company-leaders-and-the-evolving-new-healthcare-market/ 2010-01-19T17:06:51+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/18/electronic-information-implications-for-pharmaceutical-companies/ 2010-01-18T16:40:10+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/17/pharmaceutical-company-diagnostic-development-expertise/ 2010-01-17T14:45:01+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/16/stanford-options-when-faced-with-pfizer-3-million-cme-grant-offer/ 2010-01-16T16:33:29+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/15/pfizer-provides-stanford-school-of-medicine-3-million-grant-for-cme/ 2010-01-15T18:52:02+00:00 monthly 0.6 http://www.pharmareform.com/2010/01/09/the-disappearing-pharmaceutical-sales-role/ 2010-01-09T17:03:29+00:00 monthly 0.6 http://www.pharmareform.com/2009/12/29/pharmaceutical-margin-preservation/ 2009-12-29T18:14:45+00:00 monthly 0.6 http://www.pharmareform.com/2009/12/23/favorable-health-care-reform-legislation-impact-on-pharmaceutical-companies/ 2009-12-23T18:50:35+00:00 monthly 0.6 http://www.pharmareform.com/2009/12/15/leadership-courage-to-change/ 2009-12-15T16:59:47+00:00 monthly 0.6 http://www.pharmareform.com/2009/12/07/%e2%80%9cmanaged-markets%e2%80%9d-teams-of-expertise/ 2009-12-07T21:58:04+00:00 monthly 0.6 http://www.pharmareform.com/2009/12/05/leveraging-teams-of-expertise-for-the-greatest-value/ 2009-12-05T19:46:48+00:00 monthly 0.6 http://www.pharmareform.com/2009/07/29/5-certainties-of-healthcare-reform/ 2009-11-20T20:55:32+00:00 monthly 0.6 http://www.pharmareform.com/2009/08/04/you-can-not-succeed-without-this%e2%80%a6/ 2009-11-20T20:54:56+00:00 monthly 0.6 http://www.pharmareform.com/2009/08/05/the-foundation-for-future-success/ 2009-11-20T20:54:18+00:00 monthly 0.6 http://www.pharmareform.com/2009/08/10/integrity-you-can-not-buy-these-value-adding-business-benefits/ 2009-11-20T20:53:35+00:00 monthly 0.6 http://www.pharmareform.com/2009/08/17/healthcare-reform-raises-the-bar-for-pharmaceutical-r-d/ 2009-11-20T20:53:05+00:00 monthly 0.6 http://www.pharmareform.com/2009/09/01/healthcare-reform-and-pharmaceutical-company-revenue-forecasts/ 2009-11-20T20:51:11+00:00 monthly 0.6 http://www.pharmareform.com/2009/09/14/pressure-testing-pharmaceutical-product-revenue-forecasts/ 2009-11-20T20:50:32+00:00 monthly 0.6 http://www.pharmareform.com/2009/09/22/expertise-the-essential-ingredient-for-improving-pharmaceutical-r-d-productivity/ 2009-11-20T20:49:16+00:00 monthly 0.6 http://www.pharmareform.com/2009/10/14/%e2%80%9ccritical-mass%e2%80%9d-think-mega-mergers-is-not-a-pharmaceutical-company-solution-to-healthcare-reform/ 2009-11-20T20:48:42+00:00 monthly 0.6 http://www.pharmareform.com/2009/10/21/%e2%80%9ccritical-mass%e2%80%9d-is-not-strategic/ 2009-11-20T20:48:02+00:00 monthly 0.6 http://www.pharmareform.com/2009/10/26/aligning-vision-expertise-core-competencies-and-%e2%80%9ccritical-mass%e2%80%9d/ 2009-11-20T20:47:25+00:00 monthly 0.6 http://www.pharmareform.com/2009/11/06/build-teams-of-expertise-not-%e2%80%9ccritical-mass%e2%80%9d/ 2009-11-20T20:46:42+00:00 monthly 0.6 http://www.pharmareform.com/2009/11/09/build-research-teams-of-expertise/ 2009-11-20T20:44:41+00:00 monthly 0.6 http://www.pharmareform.com/2009/07/21/welcome-to-pharmareform-com/ 2009-07-23T01:58:18+00:00 monthly 0.6